Atlas Trials

Sirolimus Effect on Hypertrophic Syndromes Related Gene PIK3CA

Clinical trial NCT02443818 · COMPLETED

Trial details

NCT number
NCT02443818
Sponsor
Centre Hospitalier Universitaire Dijon
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Segmental Overgrowth Disorders Due to PIK3CA
Start date
2015-05-01
Primary completion
2016-11-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.